Advertisement

Topics

Five stories that speak volumes about US generics market

07:41 EDT 14 Sep 2018 | in-PharmaTechnologis

As Novartis looks to sell a major chunk of its generics portfolio in the US, in-PharmaTechnologist has a look back at some of the stories this year that have signposted larger, on-going trends in the US generics market.

Original Article: Five stories that speak volumes about US generics market

NEXT ARTICLE

More From BioPortfolio on "Five stories that speak volumes about US generics market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...